The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis
- 30 September 1984
- Vol. 65 (3) , 211-227
- https://doi.org/10.1016/0041-3879(84)90079-5
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Ethambutol plus isoniazid for the treatment of pulmonary tuberculosis-A controlled trial of four regimensTubercle, 1981
- Clinical Pharmacokinetics of IsoniazidClinical Pharmacokinetics, 1979
- The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamideTubercle, 1977
- A study of two twice-weekly and a once-weekly continuation regimen of tuberculosis chemotherapy, including a comparison of two durations of treatmentTubercle, 1976
- Pharmacokinetics of isoniazid metabolism in manJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Plasma and salivary concentrations of isoniazid in man: Preliminary findings in two slow acetylator subjectsJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Co-operative controlled trial of a standard regimen of streptomycin,pas and isoniazid and three alternative regimens of chemotherapy in Britain A report from the British Medical Research CouncilTubercle, 1973
- Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazidTubercle, 1972
- The therapy of pulmonary tuberculosis in Kenya: A comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment servicesTubercle, 1970
- An improved and simplified method of detecting the acetylator phenotype.Journal of Medical Genetics, 1969